Takara Bio in stem cell licensing deal aimed at supporting cell-based therapy R&D for diabetes

Takara Bio Europe has announced a licensing agreement with Denmark’s PanCryos, a pre-clinical stage biotech company, for its clinical-grade human embryonic stem (hES) cell lines, starting material for cell therapy development.